Yoko Kojima Selected Research

Cathepsin L

7/2016

Alterations in cathepsin L expression in lung cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoko Kojima Research Topics

Disease

13	Atherosclerosis 03/2022 - 06/2003
9	Inflammation (Inflammations) 03/2022 - 08/2007
4	Neoplasms (Cancer) 01/2022 - 01/2012
4	Aneurysm (Aneurysms) 01/2018 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2010
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 03/2014
3	HIV Infections (HIV Infection) 01/2018 - 07/2009
3	Lung Neoplasms (Lung Cancer) 08/2016 - 01/2012
3	Adenocarcinoma of Lung 08/2016 - 01/2016
2	Stroke (Strokes) 12/2021 - 06/2005
2	Malignant Mesothelioma 01/2021 - 01/2012
2	Carcinogenesis 07/2016 - 01/2012
2	Vascular Remodeling 12/2014 - 10/2008
2	Neointima 12/2014 - 07/2010
2	Infections 07/2009 - 01/2007
2	Abdominal Aortic Aneurysm 05/2009 - 10/2008
2	Vascular Diseases (Vascular Disease) 10/2008 - 06/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Rupture 12/2020
1	Carcinoma (Carcinomatosis) 08/2016
1	Adenocarcinoma 08/2016
1	Lymphatic Metastasis 01/2016
1	Pathologic Constriction (Stenosis) 12/2014
1	Peripheral Arterial Disease 02/2014
1	Pulmonary Arterial Hypertension 01/2013
1	Asbestosis 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Fibrosis (Cirrhosis) 01/2012
1	Mesothelioma 01/2012
1	Silicosis 01/2012
1	Hypertriglyceridemia 08/2009
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2009
1	Diabetic Angiopathies (Diabetic Angiopathy) 05/2009
1	Aortic Aneurysm (Aneurysm, Aortic) 05/2009
1	Hypoalbuminemia 01/2008
1	Hypertension (High Blood Pressure) 06/2005

Drug/Important Bio-Agent (IBA)

5	Lipase (Acid Lipase)FDA Link 08/2009 - 10/2004
4	ApelinIBA 01/2013 - 10/2008
3	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 08/2016 - 03/2014
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2020
2	AsbestosIBA 01/2021 - 01/2012
2	LipidsIBA 12/2020 - 03/2014
2	ApolipoproteinsIBA 01/2020 - 10/2004
2	Cyclin-Dependent Kinase Inhibitor p15IBA 01/2019 - 03/2014
2	AntibodiesIBA 01/2018 - 01/2016
2	LigandsIBA 01/2017 - 03/2014
2	HDL CholesterolIBA 08/2009 - 01/2008
2	N-acetyltalosaminuronic acid (NAT)IBA 07/2009 - 01/2007
2	oxidized low density lipoproteinIBA 05/2009 - 08/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2021
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	MesothelinIBA 01/2021
1	resolvin D1IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	CholesterolIBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020
1	AnaphylatoxinsIBA 01/2020
1	CytokinesIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	ChemokinesIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	TropomyosinIBA 08/2016
1	Cathepsin LIBA 07/2016
1	ElementsIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2014
1	CalreticulinIBA 03/2014
1	Antiviral Agents (Antivirals)IBA 07/2013
1	NitrogenIBA 01/2012
1	Oxygen (Dioxygen)IBA 01/2012
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2012
1	LipopolysaccharidesIBA 01/2011
1	pitavastatin (itavastatin)FDA Link 07/2010
1	Phenobarbital (Luminal)FDA Link 07/2010
1	Apelin ReceptorsIBA 07/2010
1	Bromodeoxyuridine (BrdU)IBA 07/2010
1	Triglycerides (Triacylglycerol)IBA 08/2009
1	HIV AntibodiesIBA 07/2009
1	Nucleic AcidsIBA 07/2009
1	Pancreatic Elastase (Elastase)IBA 05/2009
1	LDL Receptors (LDL Receptor)IBA 05/2009
1	Receptor for Advanced Glycation End ProductsIBA 05/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2008
1	Messenger RNA (mRNA)IBA 06/2005
1	Ribonucleases (Ribonuclease)IBA 06/2005
1	Lipoproteins (Lipoprotein)IBA 06/2003
1	Proteoglycans (Proteoglycan)IBA 06/2003

Therapy/Procedure

5	Therapeutics 03/2022 - 01/2018
1	Stents 12/2014
1	Ligation 07/2010